Ensign Peak Advisors’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.31M Sell
321,461
-26,601
-8% -$128K ﹤0.01% 764
2026
Q2
$2.14M Buy
348,062
+90,190
+35% +$562K ﹤0.01% 727
2026
Q1
$1.27M Buy
257,872
+143,511
+125% +$735K ﹤0.01% 788
2025
Q4
$671K Buy
114,361
+99,481
+669% +$826K ﹤0.01% 887
2025
Q3
$89.7K Buy
+14,880
New +$70.7K ﹤0.01% 1689

Other funds holding CLNN

Ensign Peak Advisors's CLNN Position: Q3 2026 in Review

Ensign Peak Advisors reduced its Clene (CLNN) stake by 7.6% in Q3 2026, selling an estimated $128K and leaving 321,461 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Ensign Peak Advisors first reported a position in CLNN in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.14M in Q2 2026. 23 funds tracked by Wall St. Rank hold CLNN as of Q3 2026.

  • Ensign Peak Advisors held 321,461 shares of Clene worth $1.31M as of Q3 2026.
  • Ensign Peak Advisors sold 26,601 Clene shares in Q3 2026, an estimated $128K.
  • Clene made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #764 holding.
  • Ensign Peak Advisors first reported a position in Clene in Q3 2025 and has held it in 5 quarters since.
  • Ensign Peak Advisors's Clene position peaked at $2.14M in Q2 2026.
  • 23 funds tracked by Wall St. Rank held Clene as of Q3 2026.

Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.